ACOUSORT AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10 SEK | 0.00% |
|
-15.61% | -35.69% |
| Apr. 02 | AcouSort AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | AcouSort Raises Nearly SEK25 Million from Rights Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Calendar
2024-04-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -35.69% | 13.64M | |
| -1.82% | 41.35B | |
| +41.65% | 40.38B | |
| +2.56% | 39.05B | |
| -12.11% | 26.67B | |
| +3.09% | 24.07B | |
| -24.16% | 18.36B | |
| +22.12% | 11.6B | |
| -3.74% | 11.68B | |
| +7.75% | 11.15B |
- Stock Market
- Equities
- ACOU Stock
- News AcouSort AB
- AcouSort Shares Rise 11% After National Approval of Blood Plasma Patent Application in US
